false
Catalog
The Science and Practice of Treating Patients with ...
2 managing_chronic_opioid_prescribing_and_tapering ...
2 managing_chronic_opioid_prescribing_and_tapering_-_sarah_spencer,_do,_fasam (1080p)
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video, Dr. Sarah Spencer, an addiction medicine and family medicine specialist working in rural Alaska, discusses the management of chronic opioid prescribing and reviews the updated CDC guidelines. She highlights the unintended consequences of misinterpreting and misapplying the guidelines, such as setting de facto daily dose limits and imposing strict restrictions on prescribing. Dr. Spencer stresses the importance of assessing and treating pain using a multimodal, multidisciplinary approach and provides insights into transitioning patients from chronic opioid therapy to buprenorphine for pain management. She emphasizes the need for shared decision-making, patient-centered care, and gradual tapering to minimize withdrawal symptoms and risks. Dr. Spencer advocates for considering buprenorphine as a safer alternative to traditional opioids, especially for patients with high opioid tolerance or increased risk factors, acknowledging the challenges of insurance coverage and dosage calculations in the transition process. She also touches on the effectiveness of non-pharmacological interventions and the potential for innovative solutions to improve access to these treatments in remote areas.
Keywords
Dr. Sarah Spencer
addiction medicine
family medicine
chronic opioid prescribing
CDC guidelines
multimodal approach
buprenorphine
patient-centered care
non-pharmacological interventions
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English